5 franchise brands scored by real SBA loan performance data.
Showing 1-5 of 5 franchises in Offices of Physicians (except Mental Health Specialists)
For the discerning investor navigating the complex and rapidly expanding healthcare sector, the fundamental question often revolves around identifying a franchise opportunity that not only addresses a critical consumer need but also offers robust growth potential and a proven operational framework. American Family Careafc Urgen, with its established presence in the Offices of Physicians category, presents such an intriguing proposition, operating within a market that has seen profound shifts in patient expectations and service delivery. The broader American Family Care (AFC) network, founded in 1982 by Dr. Bruce Irwin in Birmingham, Alabama, pioneered a revolutionary approach to healthcare access, envisioning facilities equipped like emergency rooms but dedicated to providing routine care with extended hours and convenient walk-in access, directly addressing the pervasive issues of overcrowded emergency rooms and the inherent difficulties patients faced in accessing timely primary care. This foundational vision has propelled the larger AFC brand to become a prominent provider of urgent care, primary care, and occupational medicine services across the United States. While the specific American Family Careafc Urgen franchise began its franchising journey in 1960 and maintains its headquarters in HALEDON, NJ, operating 87 units with 85 franchised locations and no company-owned units, it exists within the expansive shadow of the larger American Family Care network's remarkable growth trajectory. The broader AFC network itself commenced its franchising efforts in either 2008 or 2013, steadily expanding its footprint to become the nation's largest provider of urgent care. This strategic positioning within the total addressable market for Offices of Physicians, valued at approximately $840 billion and growing at a Compound Annual Growth Rate (CAGR) of around 3.5%, underscores the profound relevance of American Family Careafc Urgen as a vital component in the evolving healthcare landscape. For franchise investors, this brand signifies an opportunity to engage with a model that is inherently designed to solve real-world problems in healthcare accessibility and efficiency, backed by a legacy of innovation and market leadership in its broader category, making it a compelling subject for PeerSense’s independent, data-driven analysis. The urgent care industry, which forms the core operational landscape for American Family Careafc Urgen, is currently experiencing an unparalleled period of expansion and transformation, driven by profound shifts in consumer behavior and healthcare economics. The U.S. urgent care centers market size was valued at an impressive USD 36.4 billion in 2025 and is projected to nearly double, reaching USD 75.0 billion by 2033, demonstrating a robust Compound Annual Growth Rate (CAGR) of 9.8% from 2026 to 2033. Another authoritative estimate places the market size at USD 34.34 billion in 2024, with expectations to grow to USD 55.07 billion by 2030 at an 8.63% CAGR from 2025. This dramatic growth is not confined to urgent care alone; the broader U.S. physician groups market, a category in which American Family Careafc Urgen operates, was estimated at USD 360.35 billion in 2025 and is projected to reach approximately USD 597.11 billion by 2035, exhibiting a CAGR of 5.18% from 2026 to 2035. Key consumer trends are unequivocally driving this demand, including an aging population requiring more frequent medical attention, the rising prevalence of chronic diseases necessitating ongoing care, continuous technological advancements enhancing diagnostic and treatment capabilities, expanded health insurance coverage increasing access, and a growing societal emphasis on preventive care. Furthermore, the modern consumer’s insatiable demand for convenience is a powerful secular tailwind for American Family Careafc Urgen; a 2019 survey revealed that nearly 25% of millennials had not visited a primary care physician in five years or more, primarily due to inconvenience, leading them to increasingly opt for the rapid, accessible services offered by urgent care centers. These centers effectively bridge the critical gap between emergency rooms, which are often overburdened and costly, and traditional primary care providers, which may have limited hours and longer appointment wait times, by offering shorter wait times, broader availability encompassing nights and weekends, and a significant reduction in overall healthcare costs. The services provided by centers in this category, including X-rays, minor trauma treatments, telemedicine consultations, physical therapy, and occupational medicine, cater to a wide spectrum of non-life-threatening medical needs, making the industry highly attractive for franchise investment due to its essential nature and sustained growth. The competitive dynamics within this burgeoning market are characterized by rapid expansion, with the number of urgent care centers in the U.S. nearly doubling from 7,220 in 2014 to 14,382 in 2023, treating over 206 million people annually, indicating a vibrant, though competitive, environment ripe with opportunity for well-positioned brands like American Family Careafc Urgen. Investing in an American Family Careafc Urgen franchise involves specific financial commitments, positioning it as a significant opportunity for qualified entrepreneurs. The initial franchise fee for an American Family Careafc Urgen location is $50,000. For context within the broader American Family Care network, the initial franchise fee for a new AFC center is $60,000, while converting an existing urgent care facility to an AFC center carries a slightly reduced initial fee of $45,000, illustrating varying entry points depending on the development model. The total initial investment for an American Family Careafc Urgen franchise demonstrates a wide range, from $149,000 to $1.95 million, reflecting the diverse possibilities in location type, build-out requirements, and whether the investment involves a new construction or the conversion of an existing medical facility. For the larger American Family Care network, the estimated initial investment for a new AFC franchise typically falls between $955,500 and $1,519,500, or in other estimates, between $1,227,774 and $1,778,851, and even $1,008,000 to $1,441,500, indicating that new, ground-up developments require substantial capital. This comprehensive investment for the broader AFC network covers significant cost components such as construction, which can range from $627,000 to $829,000, medical equipment estimated at $125,000 to $155,000, and initial medical supplies costing $15,000 to $20,000. Additional expenses include initial advertising and grand opening costs of $35,000 to $50,000, furniture at $10,000 to $15,000, office equipment and computer systems at $12,000 to $17,000, lease, utility, and security deposits ranging from $6,000 to $10,000, business licenses and permits from $500 to $2,500, signage at $8,000 to $30,000, legal and professional fees of $5,000 to $10,000, and insurance for general liability and malpractice costing $13,000 to $17,000. Notably, for converting an existing urgent care facility within the broader AFC network, the estimated initial investment ranges from $144,500 to $480,500, which aligns closely with the lower end of the American Family Careafc Urgen investment spectrum, suggesting that conversion opportunities may represent a more accessible entry point. While specific liquid capital and net worth requirements are not available for American Family Careafc Urgen, the broader American Family Care network typically requires liquid capital ranging from $500,000 to $750,000 and a net worth of $1,200,000 to $2,000,000, indicating that investment in this healthcare category generally necessitates substantial financial backing. Similarly, ongoing royalty rates and advertising fees are not available for American Family Careafc Urgen; however, the larger AFC brand typically charges an ongoing royalty fee of 6% of gross sales (with some sources indicating 6.0% to 7.0%) and a Brand Fund Contribution (advertising fund) of 1% of gross revenue or a 2% marketing fee, alongside a recommended local marketing spend of $2,000 per month. These figures provide an essential benchmark for the total cost of ownership in this premium franchise investment category. While American Family Care does not directly offer financing, it actively encourages franchisees to seek assistance from third-party lenders, a standard practice in the industry. The operational model for an American Family Careafc Urgen franchise is designed for efficiency and high-quality patient care, underpinned by comprehensive support structures that empower franchisees, even those without a medical background. Daily operations for a franchisee within the broader American Family Care network, as exemplified by Dr. Samrah Mansoor, who opened an AFC franchise in Wichita, Kansas, in 2014, involve a dynamic blend of team management, direct patient care, and strategic planning for future growth, ensuring busy yet rewarding days. The staffing requirements are significant, with the larger AFC network employing 3,500 highly trained healthcare professionals across its locations, reflecting the critical need for skilled medical personnel in delivering urgent care, primary care, and occupational medicine services. While the competitive recruitment environment and potential for high turnover costs can be a general challenge in the broader physician groups market, the robust support systems and structured environment of a franchise like American Family Careafc Urgen can help mitigate these issues. The format options are comprehensive, with clinics typically operating as walk-in centers offering diverse revenue streams including urgent care, primary care, occupational medicine, telemedicine, and lab testing services, ensuring a broad patient base and stable income. The training program for new franchisees within the broader American Family Care network is extensive, commencing with a pre-opening process that incorporates crucial training objectives, followed by an intensive two-and-a-half-day corporate training experience conducted in Birmingham, Alabama. This foundational training meticulously covers essential operational practices, healthcare management principles, and stringent patient care standards, ensuring a consistent and high-quality service delivery across all locations. The initial training culminates with an invaluable on-site visit from an experienced AFC expert, providing hands-on guidance and ensuring the correct application of all learned material in the franchisee’s specific center. Ongoing corporate support is a cornerstone of the American Family Careafc Urgen model, encompassing continuous education through conferences, webinars, conference calls, and written modules, alongside specialized module-based training for center staff to maintain up-to-date skills and knowledge. This support structure extends across various critical business functions, including sophisticated marketing strategies (digital marketing, SEO, local advertising assistance, public relations strategies), staffing guidance, administrative best practices, streamlined insurance billing processes, and comprehensive operational oversight. A distinctive advantage of the American Family Careafc Urgen model, particularly within the larger American Family Care network, is its structured franchise system that enables business professionals to successfully own and operate a medical business even without being a physician, making it accessible to a broader range of entrepreneurs. The company also provides invaluable guidance in choosing optimal locations during the early stages of business development, a crucial factor for long-term success. For multi-unit franchisees, the broader AFC network highlights significant benefits such as economies of scale, streamlined operations across multiple centers, and increased brand recognition within their respective markets, fostering sustained growth and profitability. For American Family Careafc Urgen, specific Item 19 financial performance data is not disclosed in the current Franchise Disclosure Document, meaning detailed average revenue, median revenue, or profit margins directly attributable to its 87 units are not publicly available from the FDD. However, an analysis of the broader American Family Care network, which represents a significant benchmark within the same industry category, provides valuable insights into the potential unit-level performance and overall market viability. According to the Item 19 data from the 2025 Franchise Disclosure Document for the larger American Family Care brand, the average unit volume (AUV) across 270 centers for 2024 was an impressive $1,774,747. Furthermore, the brand’s 2024 FDD also reported an average net payment in the 2023 fiscal year for locations that had opened in 2022 was $1,349,056. It is crucial for prospective investors to understand that these figures represent revenue and not profit, as profit is determined by subtracting operating costs, which can vary considerably among individual franchisees based on factors such as location, operational efficiency, and local market conditions. Despite the absence of specific Item 19 data for American Family Careafc Urgen, its FPI Score of 69, categorized as "Strong," signals a robust overall health and performance outlook according to PeerSense’s independent metrics, suggesting a well-managed and potentially lucrative franchise system. This strong FPI Score, combined with the publicly available revenue data from the larger American Family Care network, offers a compelling narrative for the potential financial success within this sector. The rapid unit count growth trajectory of the broader AFC network, which has surpassed 400 locations nationwide by
The medical aesthetics and non-invasive body transformation space sits at the intersection of two of the most powerful consumer spending trends of the decade — the $87 billion U.S. wellness industry and the $18 billion U.S. medical aesthetics market, which analysts project will expand at a compound annual growth rate of approximately 9.4% through 2030. Into this high-demand, high-margin environment steps Bodybrite, a franchise concept operating from its headquarters in Missouri City, Texas, that has built its model around delivering professional-grade aesthetic and body contouring services to a consumer base that is increasingly unwilling to accept aging, stubborn fat deposits, and skin irregularities as permanent conditions. With a total current footprint of 3 franchised units and zero company-owned locations, Bodybrite occupies a very early-stage position in the franchised medical aesthetics segment — a positioning that carries both the inherent risks of a nascent system and the potential upside of entering a category before it reaches saturation. This independent analysis from PeerSense is written not as promotional material but as a rigorous investor intelligence brief — the kind of due diligence framework a sophisticated capital allocator would demand before considering any franchise investment. The core question every prospective Bodybrite franchisee must answer is the same one that animates all early-stage franchise evaluation: does the underlying market opportunity justify the first-mover risk of joining a system with limited unit-level validation, and does the brand have the operational infrastructure to scale meaningfully in a competitive and regulated category? The medical aesthetics franchise segment is notably underserved by established national franchise chains relative to its market size — a dynamic that creates genuine opportunity for differentiated early entrants. The industry context surrounding the Bodybrite franchise opportunity is unambiguously favorable from a macro demand standpoint. The global medical aesthetics market, valued at approximately $14.5 billion in 2023, is projected to reach nearly $27 billion by 2030, representing a near-doubling of market size within a seven-year window. In the United States specifically, the non-surgical aesthetic treatment segment — which encompasses body contouring, skin rejuvenation, laser hair removal, and related services — has demonstrated recession-resilient demand characteristics, with consumer spending in this category declining by less than 8% even during the 2008 financial crisis and recovering within 18 months. The aging U.S. population is a primary structural tailwind: by 2030, all Baby Boomers will be over the age of 65, representing approximately 73 million Americans with above-average discretionary income and heightened interest in appearance maintenance and wellness investment. Simultaneously, Millennial and Gen Z consumers have normalized aesthetic treatments at younger ages than any previous generation — survey data from the American Society of Plastic Surgeons consistently shows that non-surgical procedures among patients under 40 have grown by double-digit percentages year over year since 2018. The "medspa" category — medical spas operating under physician oversight or in compliance with state medical practice statutes — has grown from approximately 5,431 locations in 2018 to an estimated 8,841 locations in 2023 according to the American Med Spa Association, representing 63% unit growth in five years. This fragmented, high-growth landscape is precisely the kind of market environment that franchise models are designed to systematize and capture — and it is the competitive backdrop against which the Bodybrite franchise must be evaluated. Because Bodybrite has not publicly disclosed its investment figures through channels captured in franchise research databases, investors evaluating the Bodybrite franchise cost and investment parameters must engage directly with the franchisor to obtain a current Franchise Disclosure Document, which under FTC franchise rules must be provided at least 14 calendar days before any agreement is signed or money is paid. What can be contextualized is the typical investment range for comparable medical aesthetics and body contouring franchise concepts, which serves as a meaningful benchmark. Medspa and aesthetic franchise systems of comparable scale and service offerings typically carry total initial investment ranges between $150,000 and $600,000, depending heavily on whether the model requires a full clinical build-out with specialized equipment — body contouring machines, laser platforms, and RF devices can individually cost $30,000 to $150,000 per unit — or whether the franchise operates with a more standardized and compact format. Initial franchise fees in the medical aesthetics franchise segment generally range from $25,000 to $50,000 for single-unit rights, with royalty structures typically falling between 5% and 8% of gross revenue plus an advertising contribution of 1% to 3%. The regulated nature of the category also introduces compliance-related costs that generic retail or food franchise systems do not face — state medical practice act requirements, physician oversight arrangements, and clinical staff licensing costs vary significantly by state and can add $15,000 to $40,000 in annual operating expense depending on the jurisdiction. Investors considering the Bodybrite franchise investment should factor these category-specific cost structures into their underwriting, and should request a detailed Item 7 investment breakdown in the FDD before making any capital commitment. Understanding what daily operations look like inside a Bodybrite location is central to evaluating fit and franchisee readiness. The franchise operates within the "Offices of Physicians (except Mental Health Specialists)" category as classified by standard business taxonomy, which signals that the operating model involves services delivered under some form of medical oversight — a structural characteristic that meaningfully differentiates this concept from unregulated beauty or wellness businesses. In practice, medical aesthetics franchises of this type typically require a combination of licensed clinical staff — including medical aestheticians, registered nurses, nurse practitioners, or physician assistants depending on the state — and front-of-house client services personnel. Staffing a single medical aesthetics location typically requires a minimum of 3 to 6 employees across clinical and administrative roles, with labor representing approximately 30% to 40% of revenue in well-run operations. The operational complexity of a physician-category franchise is higher than food service or retail franchise systems because of the dual-track management required — maintaining both clinical compliance and business performance simultaneously. Training programs in comparable medical aesthetics franchises typically span 5 to 14 days of initial training, combining classroom instruction in brand protocols, equipment operation, client consultation methodology, and business management with hands-on clinical training. Territory structure in this category is generally geography-based with some form of protected radius or population-based exclusivity, and the relatively small current unit count of 3 total Bodybrite locations suggests that territory availability across most U.S. markets remains essentially open — a significant advantage for investors who act early in a franchise system's development. The ideal Bodybrite operating model appears oriented toward owner-operators or semi-absentee owners with clinical management experience or the ability to hire a qualified clinical director. Item 19 financial performance data is not disclosed in the current Franchise Disclosure Document for the Bodybrite franchise. This is a material data gap for prospective investors and deserves direct acknowledgment: without Item 19 disclosure, there is no franchisor-verified average revenue, median unit volume, or earnings claim available for third-party validation. Approximately 57% of franchise systems in the United States do not include an Item 19 earnings claim in their FDD, according to franchise industry research, meaning Bodybrite is not unusual in this omission — but it does place the burden of financial validation entirely on the investor's own due diligence. To construct a reasonable revenue benchmark, investors can reference industry data for comparable medspa and body contouring concepts. The American Med Spa Association's 2023 State of the Industry Report found that the median medical spa generated approximately $1.08 million in annual revenue, with top-quartile performers exceeding $2.2 million and the bottom quartile generating under $500,000. Single-treatment-category aesthetic studios focused specifically on body contouring — a more narrowly defined model than full-service medspas — tend to generate between $350,000 and $900,000 annually depending on market size, pricing strategy, and client retention rates. With only 3 franchised units currently in operation, the Bodybrite system does not yet have the unit-count density required to generate statistically meaningful cross-location financial benchmarks — a reality investors must internalize. Prospective franchisees are strongly advised to conduct franchisee validation calls with all three existing operators, request actual financial statements or P&L summaries from those operators voluntarily, and engage a franchise attorney and CPA with specific medical business experience before committing capital. The growth trajectory of the Bodybrite franchise is best understood as genuinely early-stage — a characterization that is descriptive rather than pejorative, but that carries specific risk and opportunity implications. With 3 total units all operated as franchised locations and no corporate-owned flagship stores providing a proven operational template, the system is at a stage of development where the foundational infrastructure of franchising — field support capability, supply chain relationships, proprietary technology, and brand marketing reach — may still be in formation. The medical aesthetics industry as a whole is, however, experiencing a structural consolidation wave that is attracting both private equity capital and franchise investment at an accelerating pace. Between 2019 and 2023, private equity transactions in the medical aesthetics space totaled over $3 billion globally, signaling institutional recognition of the category's margin profile and growth durability. For a franchise system like Bodybrite, which is headquartered in the greater Houston metro area — one of the fastest-growing major U.S. markets with a population of approximately 7.3 million in the greater metropolitan statistical area — geographic proximity to a large and demographically diverse consumer base provides a natural testing ground for proof-of-concept expansion. The competitive moat for any medical aesthetics franchise ultimately rests on four pillars: clinical outcomes that generate verifiable before-and-after results, consumer trust in the brand's safety and efficacy claims, pricing accessibility relative to non-franchised medspa competitors, and the operational consistency that a franchise system is specifically designed to deliver. Bodybrite's ability to build these moats will determine whether its 3-unit foundation evolves into a regional or national brand over the next five to ten years. The ideal Bodybrite franchise candidate is likely someone who combines entrepreneurial drive with comfort in a regulated, service-intensive business environment. Unlike food service or retail franchise systems that can be operated by investors with purely general business backgrounds, a physician-category medical aesthetics franchise demands either direct clinical experience or the demonstrated ability to recruit, manage, and retain licensed clinical personnel in a competitive healthcare labor market — where registered nurses and nurse practitioners with aesthetics experience command salaries of $65,000 to $95,000 annually in most U.S. markets. Investors with backgrounds in healthcare administration, dermatology practice management, physical therapy, or high-end personal services will find the operational demands of the Bodybrite model more intuitive than those with backgrounds exclusively in food, retail, or light-industrial franchising. From a territory standpoint, the current 3-unit presence of the Bodybrite system means that virtually all U.S. markets are effectively greenfield opportunities — investors in major metropolitan areas, suburban growth corridors, and secondary cities with above-median household incomes (the core demographic for elective aesthetic services skews toward households earning $75,000 or more annually) should evaluate this as a genuine first-mover opportunity. Multi-unit development potential exists in markets large enough to support multiple locations, and engaging the franchisor early about area development rights in target geographies is a logical first step in the conversation. The timeline from franchise agreement execution to opening in medical aesthetics concepts typically ranges from 90 days for conversion of an existing clinical space to 12 months for a full ground-up build-out with specialized equipment installation and state licensing processes. Any serious investor evaluating the Bodybrite franchise opportunity deserves a fully transparent synthesis of what the data supports and what it does not yet tell us. What the data clearly supports is this: Bodybrite operates in a category — non-invasive medical aesthetics and body contouring — that is growing at roughly twice the rate of the broader U.S. economy, serves a consumer base with strong willingness-to-pay and high service loyalty, and occupies a structural position in the market that is under-franchised relative to its size. The U.S. medical aesthetics market's projected expansion to $27 billion by 2030 creates genuine demand runway for well-positioned franchise systems. What the data cannot yet confirm is whether Bodybrite specifically has developed the franchisee support infrastructure, the validated unit economics, and the brand marketing capability to capture meaningful share of that opportunity — and with only 3 operating units and no Item 19 financial disclosure, that validation simply requires more time, more units, or more direct franchisee diligence. This is precisely the due diligence challenge that franchise intelligence platforms are built to address. PeerSense provides exclusive due diligence data including SBA lending history, FPI score analysis, location maps with Google ratings, FDD financial data, and side-by-side comparison tools that allow investors to benchmark Bodybrite against comparable medical aesthetics and wellness franchise concepts across every dimension of investment quality. The Bodybrite franchise currently holds an FPI Score of 20, classified as Limited, which PeerSense defines as reflecting the early-stage nature of the system's performance data and should be interpreted as a signal to conduct especially thorough franchisee validation and legal review rather than as a disqualifying indicator. Explore the complete Bodybrite franchise profile on PeerSense to access the full suite of independent franchise intelligence data.
The question every prospective investor must answer before committing capital to a healthcare franchise is deceptively simple: does this brand solve a problem large enough, for a demographic growing fast enough, to sustain a business through the inherent complexity of physician-led care delivery? BodyLogicMD was founded in 2003 in Boca Raton, Florida, by Patrick Savage, who serves as both the company's CEO and its founding visionary. The model Savage built was designed to address one of the most underserved categories in American healthcare — hormonal imbalance, accelerated aging, diminished vitality, and the cascade of metabolic conditions that affect tens of millions of adults, particularly those in the baby boomer generation moving through their fifties, sixties, and beyond. BodyLogicMD operates as a network of physician-owned practices, a structural distinction that separates it from corporate-owned clinic chains and gives each franchise location a credentialed medical authority at its center. Dr. Jennifer Landa serves as Chief Medical Officer, overseeing clinical protocols across the entire BodyLogicMD network. The company has built its reputation around bioidentical hormone replacement therapy, functional medicine, nutrition counseling, fitness guidance, and anti-aging wellness programs that compete not just on treatment efficacy but on the personalized, concierge-style patient experience that traditional primary care has largely abandoned. According to the most recent data available, BodyLogicMD operates in approximately 50 locations across 32 states, serves 17,000 active patients, and employs 70 practitioners — a national footprint that positions it as one of the most established and fastest-growing networks in integrative medicine, with over two decades of operating history. The total addressable market for the Offices of Physicians category — where BodyLogicMD is formally classified — reached $749.5 billion in recorded sales in 2025, with the broader physician services market estimated at $840 billion. This independent analysis is produced to serve investors making high-stakes capital allocation decisions, not to market the franchise on behalf of its franchisor. The industry landscape in which BodyLogicMD competes is defined by structural tailwinds powerful enough to make even a modestly executed franchise strategy viable over a long time horizon. The U.S. physician groups market was estimated at $349.49 billion in 2024 and is projected to grow at a compound annual growth rate of 7.62 percent from 2025 through 2030, according to current market research. A separate valuation placed the same market at $305.88 billion in 2024, with a projected trajectory to $444.79 billion by 2032 at a CAGR of 4.8 percent. The broader Medical Offices of Physicians and Specialists industry recorded an annual growth rate of 6.8 percent over the past five years, a figure that exceeds the growth rate of most retail or food-service franchise categories by a meaningful margin. Several macro forces are compounding simultaneously: the aging of the baby boomer generation is dramatically increasing demand for the specific services BodyLogicMD delivers — hormonal balance, sexual wellness, weight management, and preventive care — while rising consumer health awareness is driving a generational shift toward proactive, personalized medicine rather than reactive sick-care visits. The prevalence of chronic conditions including diabetes, cardiovascular disease, and metabolic syndrome continues to expand the universe of potential patients who benefit from the functional medicine approach BodyLogicMD practices. Technological advancement in diagnostics, combined with the expansion of telemedicine capabilities, has made it structurally easier for franchise networks to serve patients across wider geographies without proportional increases in fixed overhead. BodyLogicMD's inclusion of telemedicine and home-testing options in its service menu positions the brand directly in front of this shift. The physician services industry remains relatively fragmented at the independent practice level, with a well-documented consolidation trend driven by private equity acquisition of small practices — a dynamic that paradoxically creates opportunity for organized franchise networks to offer solo practitioners a credible alternative to hospital acquisition or private equity buyout. BodyLogicMD is recognized as one of the most established and fastest-growing networks in integrative medicine, a category that sits at the intersection of several of these converging secular trends. The BodyLogicMD franchise investment requires a meaningful but not prohibitive capital commitment that places it in the accessible-to-mid-tier range of healthcare franchise opportunities. The initial franchise fee ranges from $50,000 to $70,000, with the specific fee amount indexed to market size — a $50,000 fee applies to smaller markets, while fees of $66,000 and $70,000 correspond to markets with larger populations of potential patients. This tiered fee structure is notable because it directly ties the upfront cost to the revenue opportunity embedded in the territory, a franchise design choice that aligns franchisor and franchisee incentives from day one. Total initial investment to open a BodyLogicMD franchise is estimated between $85,100 and $182,650, with a closely corroborating estimate placing the range at $80,800 to $183,000. The spread between the low and high ends of this range is driven by geography, local real estate costs, market size, and the degree of build-out required versus a conversion of an existing medical practice space. Working capital requirements are estimated at $25,000 to $75,000, with a noted minimum cash requirement of $20,000 — this working capital is explicitly designed to cover three months of operating expenses including employee salaries, taxes, insurance premiums, rent, utilities, telephony, business internet, technology support, and routine day-to-day expenses. The franchise fee and total investment structure are inclusive of training and territory fees, meaning the headline investment figures represent a relatively complete picture of upfront costs rather than a base number subject to significant upward revision. For context, the professional services franchising category typically carries royalty fees in the 8 to 12 percent range based on industry benchmarks, and marketing or advertising fees in comparable health and fitness franchise categories run approximately 4 percent of gross revenue. The all-in total investment ceiling of approximately $183,000 is substantially lower than most healthcare clinic franchise concepts that require dedicated medical buildouts, imaging equipment, or pharmacy integrations — a structural affordability advantage that makes the BodyLogicMD franchise cost accessible to a broader pool of qualified physician candidates and physician-partnered investors. The daily operating model of a BodyLogicMD franchise is built around a physician-led, patient-centric care delivery structure that requires a qualified medical practitioner at its core. Franchisees engage patients through a combination of in-office consultation days and telemedicine visits, with the flexibility of virtual care delivery allowing the practice to serve patients across state lines in the 30 states where BodyLogicMD's network operates through telemedicine. The staffing model is lean relative to traditional medical practices — each franchise location is assigned a dedicated Sales Executive, a Concierge Service Representative, and a Business Optimization Agent provided through corporate support infrastructure, which meaningfully reduces the administrative hiring burden on the franchisee at launch. The initial training program runs approximately two weeks and is conducted at corporate headquarters in Boca Raton, Florida, covering clinical protocols, business operations, technology platforms, and patient acquisition systems. The four-step onboarding process moves sequentially through a program demonstration, agreement signing, onboarding training completion, and enrollment in monthly clinical and financial reviews — a structured cadence that provides franchisees with both initial competency and ongoing accountability. Territory structure is tied directly to the initial franchise fee paid, with larger market territories commanding the $66,000 to $70,000 fee tier, giving franchisees clear visibility into what geographic scope they are purchasing. Ongoing support includes computer and technology platforms, business development resources, and the continued involvement of the three dedicated support roles assigned at launch. The monthly clinical and financial review cadence is a distinctive structural element that keeps franchisee performance visible to corporate on a regular basis, enabling early intervention when a location underperforms relative to benchmarks. Item 19 financial performance data is not disclosed in the current Franchise Disclosure Document in a form that provides specific average revenue per unit, median revenue, or profit margin figures. The FDD does confirm that BodyLogicMD makes financial performance representations in Item 19, and that "revenue" in that context means total revenue realized from operation of the franchise — but the disclosure explicitly states that net profit information is excluded because it varies significantly from franchisee to franchisee depending on factors including the number of patient consultation days per week, hours scheduled for visits, and the franchisee's pricing decisions for consultations. The FDD also notes that expense and cost information is not included in the Item 19 disclosure, which limits the ability to construct a fully modeled unit economics picture from the FDD alone. That said, the available operational data provides meaningful context: the network serves 17,000 active patients across approximately 50 locations, implying an average active patient count of roughly 340 patients per location. The physician groups and functional medicine segment in which BodyLogicMD operates benchmarks revenue per patient visit in the range typical for integrative and concierge-style medicine practices, which generally command premium pricing relative to standard primary care due to the personalized, time-intensive nature of consultation and ongoing treatment monitoring. The company's recognition as a Top 10 Hormone Provider of 2023 signals competitive market validation. Investors should request the full Item 19 disclosure from BodyLogicMD directly and conduct detailed financial modeling based on the specific market, patient volume assumptions, and pricing strategy applicable to their target territory before committing capital. BodyLogicMD's growth trajectory reflects an organization that has moved from a regional concept to a nationally recognized integrative medicine franchise network over two decades of operation. The 2020 Franchise Disclosure Document reported 47 franchised locations operating in 29 states, with the West region representing the densest concentration of units at 15 locations — a data point that suggests either a coastal market strategy or organic physician interest clustering in that region. More recent CEO-level data indicates the network has reached 50 locations across 32 states with 70 practitioners, demonstrating measurable geographic expansion since the 2020 FDD baseline. The BodyLogicMD website's current "About Us" language describes approximately 40 affiliated practitioners in 24 franchise practice locations serving 30 states through a combination of in-office and telemedicine visits, reflecting the network's hybrid service delivery model. The competitive moat BodyLogicMD has constructed rests on several structural pillars: 17-plus years of brand equity in a category — bioidentical hormone replacement therapy and functional medicine — that has seen dramatically increased consumer awareness and acceptance over that period; a physician-owned practice model that lends clinical credibility that purely commercial wellness brands cannot easily replicate; and a telemedicine-integrated service delivery system that expands the effective patient catchment area beyond what physical office locations alone could reach. The company's recognition as a Top 10 Hormone Provider of 2023 provides third-party validation of its clinical positioning. CEO Patrick Savage has made explicit expansion plans a stated corporate priority, with the company actively seeking to expand into new markets and offering partnerships to clinics looking to broaden their service offerings — a dual-channel growth strategy that combines traditional franchise development with clinical partnership agreements. The broader consolidation trend in physician services, in which solo practitioners face pressure from hospital acquisition and private equity aggregation, creates a fertile environment for a franchise model that offers independence with infrastructure. The ideal BodyLogicMD franchisee candidate is, by the nature of the model, either a licensed physician or a physician-partnered investor who can recruit and credential a qualified medical practitioner to serve as the clinical anchor of the practice. The physician-owned structure is not incidental — it is foundational to the brand's clinical credibility and regulatory compliance framework. Candidates with backgrounds in internal medicine, family practice, endocrinology, or integrative medicine are structurally well-positioned to leverage the BodyLogicMD platform without requiring extensive clinical reorientation. The franchise agreement's territory structure means that market selection at the time of investment directly determines the size of the addressable patient population and the corresponding fee paid — a prospective franchisee targeting a major metropolitan market should anticipate the $70,000 franchise fee tier and total investments in the upper range of the $80,800 to $183,000 investment window. The telemedicine component of the operating model allows franchisees in geographically smaller markets to extend patient reach across state lines, partially mitigating the patient volume limitations of smaller physical territories. Available territories span the United States, with 32 states already represented in the network and the company actively seeking expansion into underserved markets. Monthly clinical and financial reviews create an ongoing accountability structure, and the four-step onboarding process from agreement signing to operational launch is designed to move new franchisees into patient-generating activity efficiently. Multi-unit development is a potential pathway for physicians or medical practice groups seeking to deploy capital across multiple markets under the BodyLogicMD system. BodyLogicMD represents an investment thesis that merits rigorous, structured due diligence from any investor seriously evaluating the convergence of healthcare franchise growth, aging demographics, and integrative medicine demand. The brand operates at the intersection of a $749.5 billion physician services market growing at 6.8 percent annually and a specific functional medicine niche where consumer adoption is accelerating as baby boomers seek solutions beyond what conventional medicine offers for hormonal, metabolic, and longevity-related conditions. The BodyLogicMD franchise opportunity carries a PeerSense FPI Score of 45, classified as Fair, which signals that investors should conduct thorough independent financial analysis before committing — particularly given the absence of disclosed net profit data in the current FDD and the mixed employee feedback in publicly available reviews. The total investment range of $80,800 to $183,000 with a franchise fee between $50,000 and $70,000 is competitive for a healthcare franchise in a high-growth category, but franchise investment decisions of this magnitude require more than marketing materials and a compelling market narrative. PeerSense provides exclusive due diligence data including SBA lending history, FPI score analysis, location maps with Google ratings, FDD financial data, and side-by-side comparison tools that allow investors to evaluate BodyLogicMD against comparable franchise opportunities across the physician services and healthcare wellness categories. The combination of a 20-year operating history, a 50-location national network serving 17,000 active patients, Top 10 Hormone Provider recognition in 2023, and a $840 billion total addressable market creates a foundation for a serious investment conversation — but the right conversation starts with complete data. Explore the complete BodyLogicMD franchise profile on PeerSense to access the full suite of independent franchise intelligence data.
Navigating the intricate landscape of franchise opportunities in the burgeoning wellness sector presents a significant challenge for prospective investors, who often grapple with the fear of misallocating capital into an unproven or undifferentiated brand. Understanding the true potential and operational realities of a franchise requires an authoritative, data-driven analysis, precisely what PeerSense delivers. Liquivida, a prominent full-service wellness brand, positions itself as a guide for individuals seeking to capitalize on the profound shift towards proactive "well-care," offering a comprehensive model that aims to help clients replenish, rehydrate, and revitalize their health within a modern, spa-like environment. The journey of Liquivida began as an innovative concept within a Coconut Creek, Florida, medical spa in 2013, quickly evolving into its first dedicated vitamin IV therapy storefront lounge in Fort Lauderdale's Galt Mile area by 2014, a pivotal expansion facilitated by a partnership with the board-certified physician Dr. Samuel Hess. The company's vision was spearheaded by its founder and CEO, Samael "Sam" Tejada, a retired firefighter and paramedic, whose mission was to democratize preventative medicine, a philosophy further honed through mentorship from age-management pioneer Dr. Robert D. Willix Jr. Shayna Tejada, the Co-Founder and Chief Financial Officer, meticulously oversees the brand's financial strategy and plays a crucial role in its franchise development, while Dr. Christopher Davis serves as the Chief Medical Officer, ensuring clinical excellence. From its origins, Liquivida has successfully transformed into a multi-million-dollar enterprise, establishing its headquarters in Fort Lauderdale, Florida, and strategically expanding its footprint. The brand initiated its franchise offerings in 2019 or 2020, and as of the database data, Liquivida currently operates with 14 total units, 11 of which are franchised, alongside 3 company-owned locations. Further insights from December 2025 indicate "over a dozen locations" across key markets including South Florida, Connecticut, New Jersey, Texas, and Arizona, with other sources citing 16 locations, 15 total U.S. locations for Liquivida Lounge, or 12 franchised Liquivida locations spread across 4 states: Arizona, Florida, New Jersey, and Texas, with the Southern region hosting 7 of these units. This strategic expansion places Liquivida firmly within the U.S. Physician Groups Market, which alone was estimated at USD 349.49 billion in 2024 and is projected to achieve a robust CAGR of 7.62% from 2025 to 2030, highlighting the significant total addressable market for this franchise opportunity. The broader U.S. healthcare market further underscores this potential, having reached approximately $4.8 trillion in 2024 and projected to grow to $5.15 trillion by 2026, with a sustained CAGR of 5-6% through 2030, ultimately expected to exceed 20% of the GDP by 2030. This extensive market context demonstrates why Liquivida matters to discerning franchise investors, offering a compelling entry point into a resilient and expanding industry, backed by a structured operational model and an experienced leadership team. The industry landscape in which Liquivida operates is characterized by powerful and sustained growth, driven by fundamental shifts in consumer behavior and an aging demographic. The anti-aging, medical aesthetics, and proactive wellness sectors, which form the core of Liquivida's offerings, were projected to rebound at an impressive 8% compounded annual growth rate (CAGR) from 2021, reaching an estimated $430.6 billion in 2023. Within this expansive market, the medical spa industry, a direct comparator for the Liquivida Wellness Center model, reported an average annual revenue of $1.5 million in 2019, reflecting a double-digit increase since 2017, even before factoring in the significant revenue streams generated by vitamin IV therapy or specialized weight loss solutions. The specific segment of IV therapy and general wellness has experienced particularly notable growth, fueled by a growing consumer desire for alternative health solutions, preventative care, and efficient recovery treatments. These secular tailwinds are further amplified by the broader U.S. Physician Groups Market, which, as previously noted, was valued at USD 349.49 billion in 2024 and is projected to expand at a 7.62% CAGR from 2025 to 2030. This growth is not merely organic; it is actively supported by government initiatives aimed at improving revenue cycles, a systemic shift towards value-based care models, and a discernible trend of solo practitioners integrating into larger physician groups or corporate-owned practices. Indeed, the number of physicians employed by hospital or corporate-owned practices surged by 28.9% between 2019 and 2022, increasing from 375,400 to 484,100, indicating a clear professional consolidation that favors structured, branded wellness solutions like Liquivida. Consumer trends are unequivocally leaning towards preventative wellness and aesthetic treatments, with per capita spending on healthcare expected to rise from $16,570 in 2024 to $24,200 by 2033. This robust demand creates a fertile ground for franchise investment, especially for brands like Liquivida that differentiate themselves by offering a comprehensive, full-service wellness center approach, seamlessly combining IV nutrient therapy with medical weight loss, hormone replacement, regenerative medicine, sexual wellness, and advanced aesthetics within a luxurious, spa-like setting. The industry, while somewhat fragmented at the local level, presents opportunities for consolidated, branded players to establish market dominance through consistent quality and comprehensive service offerings, making a Liquivida franchise an attractive proposition. The investment profile for a Liquivida franchise is structured to accommodate varying levels of capital and operational engagement, offering both a Lounge and a Wellness Center format, each with distinct financial requirements. For a Liquivida Lounge, the initial franchise fee is $40,000, while the more extensive Wellness Center commands an initial franchise fee of $75,000. Recognizing the invaluable contributions of service members, Liquivida extends a discounted initial franchise fee for qualifying U.S. military veterans and first responders, setting it at $6,000 for their first franchised Lounge and $11,250 for a Wellness Center. The total initial investment range for a Liquivida Lounge is estimated between $108,460 and $150,095, reflecting a more accessible entry point into the wellness market. Conversely, the investment for a comprehensive Liquivida Wellness Center is substantially higher, ranging from $645,375 to $929,600, with other general investment ranges cited between $108,000 and $930,000, and from $620,840 to $1,025,276 in the database, underscoring the premium nature of this opportunity. Specific expenditure categories for a Liquivida Wellness Center further detail this investment, including an initial franchise fee of $40,000, leasehold improvements typically ranging from $3,500 to $7,000, and a significant allocation for furniture, fixtures, and equipment between $610,500 and $812,500, which accounts for the specialized medical spa technology. Signage costs are estimated between $5,000 and $24,000, and startup inventory and supplies require an investment of $72,500 to $103,000. To support these substantial investments, a franchisee for a Liquivida Wellness Center must possess at least $75,000 in liquid capital, while a Liquivida Lounge requires a minimum cash of $145,000. The estimated working capital for operations falls between $150,000 and $225,000, indicating the need for robust financial backing. Ongoing fees include a royalty fee of 6.00% of gross revenue, paid monthly, which aligns with industry standards for service-based franchises. Additionally, a national brand fund advertising fee of $4,500 per month is required for a Liquivida Lounge, or franchisees must commit to spending at least $3,000 per month on local marketing, either directly to the franchisor or an approved marketing provider. Considering the comprehensive service offerings and specialized medical equipment, the total cost of ownership positions Liquivida as a premium franchise investment within the wellness sector, exceeding some sub-sector averages, yet offering significant potential returns in a high-demand market. The provision of veteran incentives highlights a commitment to accessible entrepreneurship for qualified individuals. The operational model for a Liquivida franchise is designed for efficiency and high-quality service delivery, supported by a comprehensive corporate structure. Daily operations for a franchisee focus on meticulous customer service, strategic sales initiatives, and seamless operational execution, ensuring a superior client experience within the spa-like environment. A critical aspect of the Liquivida business model involves staffing requirements, as all treatments, including vitamin IV therapy and aesthetic services, must be performed by highly qualified medical professionals such as nurse practitioners, physician assistants, or medical doctors, in strict adherence to state medical regulations and certification requirements. While medical expertise is paramount for treatment delivery, franchise owners themselves are not required to possess a medical background, but rather a profound passion for health and wellness, allowing them to concentrate on the business management aspects. Liquivida offers two distinct format options to accommodate various market entry strategies: the full-service Wellness Center, typically a standalone storefront model, and the Liquivida Lounge, which can be integrated within an existing medical practice or wellness facility, providing flexibility for franchisees. The training program for new Liquivida Lounge franchisees is extensive, spanning a six-month period, meticulously focusing on the crucial elements of customer service excellence, effective sales techniques, and streamlined operational procedures. This initial training is further detailed as a robust 115-hour program, comprising 35 hours of intensive classroom instruction complemented by 80 hours of hands-on, on-the-job training conducted at the corporate location, ensuring franchisees are thoroughly prepared. Following the successful opening of a new location, Liquivida provides ongoing, on-site business coaching, a vital support mechanism designed to assist franchisees in fine-tuning their performance and optimizing their unit's profitability. The ongoing corporate support structure is hands-on and multifaceted, encompassing assistance with strategic market selection and precise territory execution. Franchisees receive expert direction on the physical construction and build-out of their chosen space, along with a clear, detailed outline of necessary baseline equipment, streamlining the setup process. The brand also actively supports recruitment and team-building efforts, crucial for assembling a highly skilled and customer-focused staff. Furthermore, comprehensive training and development of standard operating procedures are provided, ensuring consistent service quality across the entire Liquivida network. Franchisees benefit significantly from corporate marketing initiatives, robust lead-generation programs, and impactful brand-wide campaigns. Innovative tools such as Liquivida TV are deployed to facilitate effective cross-selling and upselling of services, maximizing revenue potential. The comprehensive franchise package also includes legal and management support, strategically designed to help franchisees manage overhead costs and maintain a lean operational footprint, enabling them to focus on business growth while the executive team provides critical support in medical innovations, dynamic marketing, and expanding service portfolios. While a specific list of available territories is not publicly provided, Liquivida is actively expanding its franchise system across the United States, identifying market opportunities in underserved Northeast corridor markets, particularly in Massachusetts and Pennsylvania, where demographic profiles, characterized by median household incomes above $75,000 and concentrations of professional workforces, align perfectly with the successful existing locations. The 10-year term length for the franchise agreement provides a stable long-term framework for investment and growth. Liquivida provides comprehensive financial performance representations in Item 19 of its Franchise Disclosure Document, offering transparent insights into potential earnings for prospective investors, a practice that, while not mandatory for all franchisors, significantly enhances due diligence. The disclosed data reveals an average revenue of $1.27 million across the system, with a median revenue of $1.25 million, demonstrating consistent performance among its units. Particularly compelling is the top quartile revenue, which reaches an impressive $2.66 million, indicating substantial earning potential for well-managed locations within prime markets. This spread between average and top-quartile performers is often driven by factors such as strategic location, effective local marketing, superior customer service, and adept operational management, allowing top-tier franchisees to significantly outperform the system average. For Liquivida Wellness Centers specifically, the average gross revenue for Fiscal Year 2023 was reported at $1,147,288, providing a concrete benchmark for this format. When considering the Liquivida Lounge model, yearly gross sales are estimated at $925,997, with estimated earnings ranging from $129,640 to $166,680, offering a clear picture of potential owner compensation. Another reported average gross revenue for Liquivida Lounge units stands at $867,285, which, while robust, is noted as falling below the sub-sector average of $1,225,544. This difference is largely attributed to the system's relatively recent establishment in 2017 (for operational purposes, though franchising started in 2019/2020) and its comparatively smaller operational footprint of 13 units at that time, suggesting significant room for growth as the brand matures and expands. It is crucial for investors to remember that these figures represent gross revenue and not net profit, as profit is derived after deducting operating costs, which can vary significantly based on factors such as rent, labor, and local market conditions. The estimated Franchise Payback Period for a Liquivida franchise is calculated at 6.1 to 8.1 years, providing a realistic timeframe for owners to recover their initial investment, aligning with industry expectations for businesses with premium capital requirements. The FPI score of 68, classified as "Strong," further validates the robust overall health and performance potential of the Liquivida franchise system, making the Liquivida franchise revenue figures a compelling aspect for serious consideration. The growth trajectory of Liquivida since its inception in 2020 as a franchisor has been marked by strategic expansion and continuous innovation, demonstrating a strong commitment to scaling its presence across the United States. While the database indicates 14 total units with 11 franchised and 3 company-owned, other sources provide further granular detail, specifying 16 locations, 15 total U.S. locations for Liquivida Lounge, or 12 franchised Liquivida locations spread across 4 states (Arizona, Florida, New Jersey, and Texas) as of the 2025 Franchise Disclosure Document data, with 7 of these locations concentrated in the Southern region. The company is actively growing its physical presence, with recent expansion including a new location in Livingston, New Jersey, which commenced operations on July 29, 2025, and an earlier expansion into Orlando, Florida, on December 29, 2020. This consistent addition of new units, coupled with the mention of "over 40 locations" for Liquivida as a multi-million-dollar enterprise in one source, highlights an aggressive growth strategy and increasing market penetration. Liquivida's competitive moat is built upon its distinctive full-service wellness center approach, which seamlessly integrates diverse offerings beyond standard IV nutrient therapy. This includes comprehensive medical weight loss programs, hormone replacement therapy, cutting-edge regenerative medicine, sexual wellness solutions, and advanced aesthetics, all delivered within a sophisticated, spa-like setting. This holistic "Vida Journey" approach, which emphasizes diagnostics, metabolic health, and long-term prevention, differentiates Liquivida from more narrowly focused competitors. Recent corporate developments underscore this commitment to innovation and strategic partnerships. Liquivida has engaged in significant collaborations, partnering with Pico IV Inc. on August 15, 2025, Nolo Health on August 28, 2023, and NexGen Health on July 16, 2023, signaling a proactive approach to expanding its service capabilities and market reach. The company has also broadened its product offerings by adding Xeomin from Merz Aesthetics, providing clients with access to minimally invasive skin treatments, further solidifying its position across five key wellness pillars. Leadership stability is another strength, with Sam Tejada remaining at the helm as CEO and Founder, and his recent authorship of the book "How To Win In Modern Wellness" further elevates the brand's thought leadership in the industry. Tejada's personal recognition, including features in Forbes Magazine and Essence Magazine, and appearances as a health and wellness expert on various news segments, enhances the brand's public profile and credibility. These strategic expansions, product innovations, and leadership visibility collectively create a robust competitive advantage for the Liquivida franchise, allowing it to adapt to evolving market conditions and sustain its growth trajectory in the dynamic wellness industry. The ideal candidate for a Liquivida franchise is an entrepreneur with a profound passion for health and wellness, even if they do not possess prior medical experience. Given the operational complexity and the premium investment requirements, ideal investors should possess substantial liquid capital, demonstrating financial readiness to support both the initial setup and ongoing working capital needs. While not explicitly stated as a requirement, a strong management background would be highly beneficial for navigating the daily operations, which include managing qualified medical professionals, overseeing customer service, and driving sales within a regulated environment. The Liquivida franchise model is structured to support dedicated owner-operators who are actively involved in their business, focusing on the operational aspects while leveraging corporate support for medical innovations and marketing. For those considering multi-unit ownership, while specific requirements are not detailed, the robust investment and comprehensive support system suggest a scalable model for successful franchisees. Liquivida is actively expanding its franchise system across the United States, with a strategic focus on identifying market opportunities in underserved Northeast corridor markets, particularly in Massachusetts and Pennsylvania. These target areas are characterized by demographic profiles that align with existing successful locations, typically featuring median household incomes above $75,000 and concentrations of professional workforces, indicating a strong potential customer base for Liquivida's premium wellness services. While a specific timeline from signing the franchise agreement to opening is not publicly provided, the extensive six-month training period, encompassing 115 hours of classroom and on-the-job training, suggests a thorough and supported ramp-up process. The franchise agreement term length is a substantial 10 years, providing franchisees with a secure and long-term investment horizon, allowing ample time to establish and grow their business within their protected territory. For astute investors seeking a significant franchise opportunity within the high-growth wellness, anti-aging, and medical aesthetics industries, Liquivida presents a compelling investment thesis. The brand's comprehensive service offerings, encompassing vitamin IV therapy, medical weight loss, hormone programs, and aesthetics, position it strategically within a market experiencing robust consumer demand for proactive health solutions. With an average revenue of $1.27 million and top-quartile units achieving $2.66 million, the financial performance potential of a Liquivida franchise is substantial, supported by a strong FPI score of 68. The detailed training, hands-on operational support, and robust corporate marketing initiatives provided by Liquivida help mitigate the complexities inherent in a medical spa model, guiding franchisees toward success. The brand's strategic partnerships and continuous innovation in services ensure it remains at the forefront of the evolving wellness landscape, while its targeted expansion into high-income, professional markets promises sustained growth. This opportunity is framed within a broader industry context where the U.S. healthcare market is projected to reach $5.15 trillion by 2026, and per capita spending is expected to rise to $24,200 by 2033, underscoring the long-term viability and increasing consumer investment in health. PeerSense provides exclusive due diligence data including SBA lending history, FPI score, location maps with Google ratings, FDD financial data, and side-by-side comparison tools, offering an unparalleled depth of independent franchise intelligence. Explore the complete Liquivida franchise profile on PeerSense to access the full suite of independent franchise intelligence data and make an informed investment decision.
Every parent has stood in a hospital emergency room at 10 PM on a Tuesday with a feverish child, watching the clock tick past midnight while the waiting room fills with trauma cases and the bill climbs toward four figures. That experience — expensive, inefficient, and stressful — is exactly the problem Your Kids Urgent Care franchise was built to eliminate. Founded in 2007 by Michael Cibran, the brand set out with a precise mission: deliver after-hours pediatric medical care in a calm, soothing clinical environment at a fraction of the cost of a hospital emergency room. The concept targets patients aged 0 to 21, filling the critical gap between a primary care physician's office hours and the prohibitively expensive emergency department. Cibran, who continues to serve as President and CEO, anchored the brand's early growth in Florida, establishing a meaningful presence in Tampa, St. Petersburg, and Orlando before expanding beyond state lines. As of the current profile data, Your Kids Urgent Care operates 3 franchised units with 0 company-owned locations, making it a lean, founder-led franchise in active development phase. The broader U.S. urgent care market was valued at USD 34.34 billion in 2024 and is projected to reach USD 55.07 billion by 2030, representing a compound annual growth rate of 8.60 percent. A separate market analysis values the sector at USD 36.4 billion in 2025 and projects expansion to USD 75.0 billion by 2033, implying a CAGR of 9.8 percent from 2026 through 2033. Within that enormous market, pediatric-specific urgent care occupies a defensible, specialized niche that commands parent loyalty in ways that general urgent care brands simply cannot replicate. This analysis is produced independently by PeerSense and represents no affiliation with or endorsement from the franchisor. The secular forces driving demand for urgent care services in the United States have not softened — they have accelerated. The number of urgent care centers in the U.S. nearly doubled between 2014 and 2023, growing from 7,220 centers to 14,382, a 99.2 percent increase in under a decade. More than 206 million people in the U.S. are treated in urgent care settings annually, a patient volume that rivals the throughput of some of the country's largest hospital networks. The pediatric segment of this industry is showing its own distinct growth signals: in 2022, 28.4 percent of children up to age 17 visited a retail health clinic or urgent care center in the previous 12 months, up sharply from 21.6 percent in 2021. The youngest cohort, children aged 0 to 5, drove the most dramatic shift, with utilization climbing from just under 20 percent in 2021 to just below 30 percent in 2022. Teenagers aged 12 to 17 reached a 30.3 percent visit rate in 2022, while children aged 6 to 11 posted a 26.6 percent rate. Visits to urgent care centers increased 14 percent between 2020 and 2021 alone, with the pandemic introducing an entirely new patient cohort to the model. Rural urgent care centers are growing 40 percent faster than their suburban counterparts, indicating that geographic white space remains substantial. The industry's competitive dynamics remain notably fragmented at the pediatric-specific level, where dedicated brands are far less common than general urgent care operators, creating a structural opening for a focused franchise system with clinical credibility and a replicable operating model. The macro tailwinds — chronic disease burden, Medicaid privatization and expansion, rising emergency room costs, and consumer preference for convenient outpatient care — all align favorably for a specialized pediatric operator. Understanding the Your Kids Urgent Care franchise investment requires careful attention to the range of capital required and the inputs that drive variability across that range. The total investment required to open a Your Kids Urgent Care franchise falls between $173,525 and $338,317, a spread that reflects meaningful variability in build-out costs, local real estate conditions, equipment configurations, and whether a location is a conversion of an existing clinical space or a ground-up fit-out. The lower end of that range — $173,525 — is notable within the healthcare franchise category, where medical build-outs routinely push total costs well above $500,000 for comparable footprints. Prospective franchisees are required to demonstrate a minimum of $100,000 in liquid capital, establishing a baseline of financial stability without requiring institutional-scale wealth to enter the system. A veterans discount is offered, which is a meaningful differentiator in a franchise category where first responder and military community alignment carries both operational and reputational value. The franchisor's management team, which includes Executive Vice President of Corporate Development and Franchising Felica Fortune in the corporate development role as of 2019, works with outside vendors to deliver a complete solution for starting a medical center, which can meaningfully reduce the capital deployment risk that first-time healthcare franchise operators typically face. Financing for healthcare service franchises can be approached through SBA loan programs, and the sub-$340,000 total investment ceiling positions Your Kids Urgent Care within a range that many SBA lenders actively support for qualified borrowers. For context, the pediatric urgent care and specialty clinic franchise category spans investment ranges from under $200,000 at the modest end to over $1 million for hospital-affiliated or multi-specialty platforms, placing Your Kids Urgent Care squarely in the accessible-to-mid-tier segment of the healthcare franchise investment landscape. The daily operating model of a Your Kids Urgent Care franchise is structured to function efficiently in the after-hours window when primary care physicians are unavailable, a positioning that concentrates patient demand into predictable time blocks and allows for targeted staffing optimization. The franchise is built to serve patients aged 0 to 21, which means staff must include clinicians credentialed in pediatric care, either physicians or nurse practitioners, with licensing requirements varying by state. The brand explicitly accommodates two distinct franchisee profiles: practicing physicians who want to own a business with proven systems already in place, and private investors or entrepreneurs who hire physicians and nurse practitioners to satisfy clinical licensing requirements. This dual-track ownership model expands the addressable pool of qualified franchisees considerably beyond the medical community alone. Franchisees receive complete training and assistance as part of the approval process, with the corporate team providing hands-on guidance across operational setup, marketing execution, accounting systems, audit protocols, and legal compliance — five distinct support pillars that together reduce the knowledge gap for first-time clinic operators. Each franchise is granted an exclusive territory of up to 100,000 in population, modeled on the demographic profiles of existing corporate locations in Tampa, St. Petersburg, and Orlando, Florida, and Vestavia, Alabama — markets sharing a median household income of more than $50,000. Clinical services include in-house pharmacy dispensary capabilities, full laboratory facilities, and on-site X-ray, which are three service lines that materially increase revenue capture per patient visit compared to urgent care models that rely on outside referrals. Your Kids Urgent Care also introduced telemedicine for minor issues such as colds, skin rashes, and sinus infections, becoming the first provider in Birmingham, Alabama, to offer this service as of August 2019, demonstrating an early commitment to virtual care integration that has since become a competitive baseline across the broader urgent care industry. Item 19 financial performance data is not disclosed in the current Franchise Disclosure Document for Your Kids Urgent Care. This is a critical data point for any prospective investor to register clearly: the franchisor has not elected to provide a Financial Performance Representation, which means there is no FDD-sourced average revenue per unit, median gross sales figure, or cost breakdown available through official disclosure channels. Item 19 disclosure is optional under FTC franchise regulations, and the majority of franchisors in early growth stages operate without it. However, the absence of this data places a greater analytical burden on prospective franchisees to conduct independent unit-level financial diligence through franchisee interviews and third-party benchmarking. What can be evaluated are industry-level benchmarks: the U.S. urgent care market generates enormous aggregate revenue across its 14,382-plus locations, and the pediatric segment specifically benefits from a 28.4 percent utilization rate among children under 17 as of 2022, a figure that continues to grow year-over-year. The brand has publicly described itself as offering "enormous profitability and revenue potential," a characterization that, in the absence of Item 19 data, must be evaluated against industry benchmarks rather than brand-specific disclosures. The PeerSense FPI Score for Your Kids Urgent Care is 41, rated Fair, which reflects the early-stage nature of the franchise system, limited unit count, and absence of financial performance disclosure — not necessarily a reflection of the underlying business model's viability. Investors should request access to current franchisee contact information from the FDD, conduct a minimum of five franchisee interviews, and benchmark the results against publicly available urgent care industry revenue data before making any capital commitment. Your Kids Urgent Care has followed a deliberate, measured expansion path since its 2007 founding, with growth milestones that chart a brand building carefully rather than scaling recklessly. The company opened its fifth location in August 2019 in Vestavia Hills, Alabama — significant because it marked the brand's first expansion outside Florida, validating the out-of-state replicability of its clinical and operational model. In September 2020, the sixth location opened in New Providence, New Jersey, extending the brand's footprint to the Northeast. In February 2024, Oviedokids announced a partnership with Your Kids Urgent Care, signaling continued brand-level development activity in the Florida market. As of 2019, the company's stated goal was to grow to more than 30 clinics across the U.S. within five years, an ambitious target that, if achieved, would represent a 400-plus percent increase from the six-location baseline. The brand's competitive moat is constructed on several reinforcing elements: a focused pediatric-only service model that commands parental trust, a multi-service clinical platform that includes laboratory, X-ray, and pharmacy dispensary under one roof, an early telemedicine integration that reduces abandonment among patients with minor conditions, and an exclusive territory structure that protects franchisee investment from intra-system competition. Your Kids Urgent Care was voted Best of 2021 Pediatric Urgent Care by Franchise Magazine, providing third-party validation of brand quality in a category where clinical reputation is the most powerful driver of patient retention. The franchise is available across an unusually broad range of states including Alabama, Arizona, Colorado, Connecticut, Florida, Georgia, Louisiana, Massachusetts, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, and more than 20 additional states, indicating that corporate infrastructure for multi-state operations is already in place. The ideal Your Kids Urgent Care franchisee falls into one of several well-defined profiles, each of which the corporate team evaluates through a structured approval process. Physicians holding an active medical license represent the most natural fit, as they bring clinical credibility, reduce licensing friction, and can directly supervise or practice in the clinic. Newly graduating physicians seeking practice ownership rather than hospital employment represent a growing cohort given the national trend toward physician dissatisfaction with large group practices and health system employment contracts. Private investors or entrepreneurs without clinical backgrounds are also considered, provided they commit to hiring qualified physicians or nurse practitioners to satisfy state licensing requirements — a model that allows capital-wealthy non-clinicians to participate in the healthcare franchise category. Corporations and businesses in the healthcare industry are evaluated on a case-by-case basis, suggesting the brand has a pathway for multi-unit or multi-site operators with institutional backing. Exclusive territories are structured around populations of up to 100,000, with demographic benchmarks drawn from the brand's existing Florida and Alabama corporate markets, both of which feature median household incomes exceeding $50,000. Available franchise states span 38 jurisdictions across the South, Northeast, Midwest, Mountain West, and Pacific Northwest, giving prospective investors a wide geographic canvas from which to identify high-demand markets. The franchise system is best suited to candidates who can operate or hire for a clinical environment, manage a small professional staff, and commit to community-level marketing in a geography where parent trust is built through visible, consistent presence. For investors evaluating the pediatric healthcare franchise category, Your Kids Urgent Care presents a distinctive combination of low-to-mid entry cost, a large and growing addressable market, and a founder-led brand with seventeen years of operating history in a clinically specialized niche. The U.S. urgent care market's trajectory from $34.34 billion in 2024 toward $55.07 billion by 2030 creates a structural tailwind that benefits any well-positioned operator, and the pediatric segment's accelerating utilization rates — rising from 21.6 percent to 28.4 percent of children under 17 in a single year — signal that demand is not cyclical but demographic. The total investment range of $173,525 to $338,317 with a $100,000 liquid capital threshold positions this as one of the more accessible entry points in the medical franchise category, particularly given the multi-service clinical platform that includes pharmacy, laboratory, and X-ray capabilities. The FPI Score of 41 reflects the system's early-stage development and the absence of Item 19 financial disclosure, both of which are factors that require elevated due diligence rather than automatic disqualification. PeerSense provides exclusive due diligence data including SBA lending history, FPI score, location maps with Google ratings, FDD financial data, and side-by-side comparison tools that allow investors to benchmark Your Kids Urgent Care against comparable healthcare franchise opportunities across investment level, territory structure, and performance indicators. The combination of a documented growth plan targeting 30-plus U.S. clinics, a veterans discount program, a 2021 industry award, and a February 2024 partnership with Oviedokids suggests a brand with ongoing market activity and development momentum. Explore the complete Your Kids Urgent Care franchise profile on PeerSense to access the full suite of independent franchise intelligence data.
Other franchise sites rely on marketing materials. We use real SBA lending data to show you what's actually happening.
See actual SBA loan default rates for every franchise brand. Know which brands have borrowers who repay — and which don't.
Discover which SBA lenders fund each brand, their approval volumes, and default performance. Get matched with the right lender.
Compare any franchise against its industry benchmarks. See if it outperforms or underperforms the sector average.
The PeerSense Franchise Directory is the most comprehensive data-driven franchise research tool available. With over 6,300 franchise brands scored by real SBA data and 133,000+ mapped locations, each profile includes our proprietary Franchise Performance Index (FPI), composite health scores, SBA lending data, geographic distribution, and FDD-sourced investment details.
Unlike other franchise directories, PeerSense uses real SBA loan performance data to evaluate franchise brands. Our data comes from 100+ industry sectors and 899+ SBA lenders, giving you an objective, data-backed view of franchise performance.
The FPI is a proprietary scoring system that evaluates franchise brands on a 0-100 scale based on SBA loan repayment performance, lender diversity, geographic reach, system maturity, lending velocity, and financial transparency.
Start by browsing popular categories like Restaurants, Hotels, Fitness Centers, or Child Day Care. You can also search by name, filter by investment range, and sort by FPI score to find top performers.
Once you find a franchise, explore its full profile for SBA lending history, health scores, FDD fees, and revenue data. Then check industry benchmarks to compare it against the sector, or find specialized SBA lenders who fund that brand. Looking to buy? Browse businesses for sale with data-backed valuations.
Found the right franchise? PeerSense connects you with 500+ capital sources to fund your deal. Explore financing solutions matched to franchise acquisitions.